IMMUNIC, INC. — Director's Dealing 2014

Apr 16, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-04-16

Reporting Person: Millis J. Michael (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	16429	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualifed Stock Option (right to buy)	$8.00	2022-09-26	Common Stock (33834)		Direct
Senior Convertible Preferred Stock	$		Common Stock (1250)		Direct

Footnotes

F1: This stock option was granted on September 26, 2012 and vests over four years. Subject to the optionee continuing to provide services, one forty-eighth of the shares subject to the option vest one month after the vesting commencement date of September 13, 2012, and an additional one forty-eighth of the shares vest at the end of each monthly period thereafter. The option is subject to an early exercise provision and is immediately exercisable.

F2: Each share of Convertible Preferred Stock is convertible at any time at the election of the Reporting Person and will automatically convert into one share of Common Stock immediately prior to the closing of the Registrant's initial public offering. There is no expiration date.